NCT06170190 2025-11-17A Multicentre,Study of IBI133 in Subjects WithUnresectable, Locally Advanced or Metastatic SolidTumoursInnovent Biologics (Suzhou) Co. Ltd.Phase 1/2 Completed19 enrolled